Modified variant Bowman Birk Protease Inhibitors
    2.
    发明授权
    Modified variant Bowman Birk Protease Inhibitors 有权
    改良型Bowman Birk蛋白酶抑制剂

    公开(公告)号:US08394941B2

    公开(公告)日:2013-03-12

    申请号:US13082979

    申请日:2011-04-08

    IPC分类号: C12N15/00

    CPC分类号: C07K14/811 A61K8/64 A61Q7/02

    摘要: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

    摘要翻译: 本发明涉及包含结合靶蛋白的肽的修饰变体Bowman Birk蛋白酶抑制剂蛋白(BBPI),并且被进一步修饰以具有比未修饰的BBPI更大的蛋白酶抑制活性和/或以更高的产量产生。 本发明包括多核苷酸构建体和含有编码修饰变体BBPI的多核苷酸序列的表达载体,表达和产生修饰变体BBPI的转化宿主细胞,修饰变体BBPI蛋白,包含修饰变体BBPI的组合物和制备方法 并在个人护理中使用修改后的变体BBPI。

    Proteases from gram-positive organisms
    4.
    发明授权
    Proteases from gram-positive organisms 失效
    来自革兰氏阳性菌的蛋白酶

    公开(公告)号:US08101563B2

    公开(公告)日:2012-01-24

    申请号:US11008352

    申请日:2004-12-08

    申请人: David A. Estell

    发明人: David A. Estell

    CPC分类号: C12N9/54 C11D3/386 C12N15/75

    摘要: The present invention relates to the identification of novel metallo-proteases (MP) in Gram-positive microorganisms. The present invention provides the nucleic acid and amino acid sequences for Bacillus MP. The present invention also provides host cells having a mutation or deletion of part or all of the gene encoding MP. The present invention also provides host cells further comprising nucleic acid encoding desired heterologous proteins such as enzymes. The present invention also provides cleaning compositions comprising an MP of the present invention.

    摘要翻译: 本发明涉及革兰阳性微生物中新型金属蛋白酶(MP)的鉴定。 本发明提供了用于芽孢杆菌MP的核酸和氨基酸序列。 本发明还提供具有编码MP的基因的部分或全部的突变或缺失的宿主细胞。 本发明还提供宿主细胞,其进一步包含编码所需异源蛋白质如酶的核酸。 本发明还提供了包含本发明的MP的清洁组合物。

    Modified Variant Bowman Birk Protease Inhibitors
    10.
    发明申请
    Modified Variant Bowman Birk Protease Inhibitors 有权
    改良变体Bowman Birk蛋白酶抑制剂

    公开(公告)号:US20100221780A1

    公开(公告)日:2010-09-02

    申请号:US12779793

    申请日:2010-05-13

    IPC分类号: C12P21/00

    CPC分类号: C07K14/811 A61K8/64 A61Q7/02

    摘要: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

    摘要翻译: 本发明涉及包含结合靶蛋白的肽的修饰变体Bowman Birk蛋白酶抑制剂蛋白(BBPI),并且被进一步修饰以具有比未修饰的BBPI更大的蛋白酶抑制活性和/或以更高的产量产生。 本发明包括多核苷酸构建体和含有编码修饰变体BBPI的多核苷酸序列的表达载体,表达和产生修饰变体BBPI的转化宿主细胞,修饰变体BBPI蛋白,包含修饰变体BBPI的组合物和制备方法 并在个人护理中使用修改后的变体BBPI。